Thank you for attending the EACR-AACR-SIC Special Conference 2017: The Challenges of Optimizing Immuno- and Targeted Therapies: From Cancer Biology to the Clinic. The AACR is accredited by the ACCME to provide continuing medical education for physicians. The AACR designates this live activity for a maximum of 20.75 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Request for Credit
To receive CME Credit you must complete the following Request for Credit Survey. A credit certificate (for physicians) or certificate of attendance (for non physician attendees) will only be issued to those who complete the survey. Your certificate will be sent by email after the survey is completed.

* 1. Contact Information

* 2. Please enter your AACR ID number (If you don't have one, please leave blank)

* 3. Address Information

* 4. Please indicate your email address

APPROVED SESSIONS WORKSHEET PDF: If you don't remember which sessions you attended, please access the following link to the Sessions Worksheet PDF: EACR-AACR-SIC Special Conference CME Sessions Worksheet

* 5. Number of Credits Claimed

* 6. Select One

* 7. Which statement best describes your practice setting?

* 8. Please rate your scope of knowledge in Immuno- and Targeted Therapies prior to participating in this CME activity.

  Little Knowledge Some Knowledge Moderate Knowledge Above Average Knowledge Extensive Knowledge
Knowledge Level

* 9. Activity included opportunity to learn interactively from faculty/participants?

  Strongly Agree Agree Neutral Disagree Strongly Disagree
Please rate

* 10. Content covered was useful and relevant to my practice?

  Strongly Agree Agree Neutral Disagree Strongly Disagree
Please rate

* 11. To what extent were the learning objectives met by this CME activity?

  Strongly Agree Agree Neutral Disagree Strongly Disagree
Demonstrate an increased understanding of how particular targeted agents and immunotherapies are selected for use in patients with advanced cancer.
Integrate the use of molecular profiling methods to select the most appropriate treatment.
Evaluate the emerging cancer treatments and their underlying biology.
Establish a greater understanding of mechanisms of drug resistance and how combination therapies may increase treatment response or durability.

* 12. The speakers presented sufficient scientific evidence to support the content presented?

  Strongly Agree Agree Neutral Disagree Strongly Disagree
Please rate

* 13. Meeting Presentations were free from commercial influence or bias?

  Strongly Agree Agree Neutral Disagree Strongly Disagree
Please rate

* 14. Please rate how likely you are to make changes in your practice in the following areas:

  Strongly Agree Agree Neutral Disagree Strongly Disagree
Improve knowledge of the contributions of laboratory research to drug development and patient care, as well as the epidemiological implications of cancer incidence and mortality.
Improved performance in incorporating critical concepts, related skills, and/or methods associated with basic cancer research into the clinical practice of oncology to aid in the detection, diagnosis, treatment, and prevention of cancer.
Improved competence in clinical research design and protocols that improve patient outcomes.
Development of new interdisciplinary collaborations to advance the progress of cancer research from “bench to bedside and back” yielding further improvements in patient outcomes.

* 15. As a result of your participation in the EACR-AACR-SIC Special Conference 2017: The Challenges of Optimizing Immuno- and Targeted Therapies: From Cancer Biology to the Clinic, what are you going to do differently? Please indicate any changes to your practice:

* 16. Please indicate any barriers you perceive in implementing changes to your practice (check all that apply).

* 17. Please rate your scope of knowledge in Immuno- and Targeted Therapies after participating in this CME activity.

  Little Knowledge Some Knowledge Moderate Knowledge Above Average Knowledge Extensive Knowledge
Knowledge Level

* 18. Please provide any additional comments or suggestions for use in planning future AACR CME activities.

Thank you for your participation in the EACR-AACR-SIC Special Conference 2017: The Challenges of Optimizing Immuno- and Targeted Therapies: From Cancer Biology to the Clinic. Your Certificate will be processed soon and sent by email.
Report a problem

T